ETTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 Jun 2024 @ 16:00):

Stats
Today's Volume	68 834
Average Volume	0
Market Cap	0.00
EPS	$-0.320 ( Q1 \| 2022-04-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.950 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0320 (1.46%)

AADI -3.53%

ABCL 2.01%

ABCM 0.04%

ABEO -2.13%

ABIO -2.23%

ABOS 0.00%

ABSI 1.87%

ABUS -2.30%

ABVX -2.03%

ACAD -0.48%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.50%

ACLX 0.09%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.01%

ADGI 0.87%

ADIL 0.54%

ADMA -2.77%

ADPT -0.15%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.25%

AKRO -2.59%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -1.38%

ALGS -1.81%

ALKS -0.21%

ALLK -8.55%

ALLO -5.00%

ALLR -3.37%

ALNA 3.16%

ALNY 2.35%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.58%

ALVR -0.40%

ALXN 0.00%

ALXO -11.12%

ALZN 2.04%

AMRN -0.72%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.75%

ANPC -3.15%

APGE -1.05%

APGN 8.48%

APGNW 30.65%

APLM -6.42%

APLS 0.50%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.72%

ARDS -14.23%

ARDX -0.58%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.30%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.85%

ARWR -1.56%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.11%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.67%

AUPH -0.90%

AURA 1.17%

AUTL -2.01%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.83%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.57%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.75%

BCAB 3.92%

BCDA -2.73%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.07%

BCTX 8.16%

BCTXW -17.41%

BCYC 1.35%

BDRX -4.94%

BDTX -0.85%

BEAM 0.93%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 4.49%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.31%

BMRN 0.50%

BNOX 4.61%

BNTC -0.42%

BNTX -1.86%

BOLD -8.58%

BOLT 0.72%

BPMC -1.01%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 24.56%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.04%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA -0.12%

CARM 10.43%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.39%

CCCC -5.11%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 7.24%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -0.91%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.19%

CGEN -3.87%

CGON -0.83%

CGTX -4.54%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.15%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.21%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.46%

CMPI 0.00%

CMPX -7.19%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -36.52%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.14%

COYA -1.46%

CPRX -1.12%

CRBP -3.34%

CRBU -4.83%

CRDF -0.89%

CRGX 0.47%

CRIS -0.38%

CRNX -5.83%

CRSP 1.22%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.85%

CTXR 2.01%

CUE 3.78%

CVAC -2.54%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 9.82%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.77%

CYTO -1.82%

DARE 6.41%

DAWN 0.37%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.55%

DNLI -1.54%

DNTH -8.81%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.96%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.70%

EDSA 3.19%

EFTR 4.64%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.45%

ELYM 2.30%

ENGN -4.44%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB -0.84%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.03%

EXAI -0.66%

EXEL -0.25%

EYEG -0.69%

EYEN 0.43%

EYPT 0.06%

FATE -8.06%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -4.18%

FENC -1.29%

FGEN -5.13%

FHTX 1.71%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.04%

FULC -3.85%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -2.16%

GLMD -2.33%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.50%

GLYC -9.53%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.91%

GNLX 1.10%

GNPX 0.98%

GNTA 3.94%

GOSS -10.47%

GOVX 4.55%

GOVXW -49.04%

GPCR -6.85%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.36%

GRTX 2.57%

GTHX 0.91%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.33%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.46%

HOOK -0.02%

HOTH -2.70%

HOWL -2.56%

HRMY 0.80%

HRTX 3.44%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -4.20%

ICCC 0.22%

ICPT 0.21%

ICU 16.30%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.24%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.99%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.81%

INAB 0.00%

INBX 0.43%

INCY -0.95%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.64%

INMB 2.66%

INO -1.95%

INSM -1.31%

INTS -2.75%

INVA 0.28%

INZY 1.03%

IOBT -11.81%

IONS 0.28%

IOVA -2.13%

IPA 2.50%

IPHA 5.58%

IPSC -1.95%

IRON -2.34%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.45%

JANX -4.18%

JAZZ -0.69%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.87%

KNTE -0.38%

KOD -6.92%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.16%

KTRA 16.23%

KTTA 8.16%

KTTAW 0.92%

KURA -1.51%

KYMR -2.60%

KYTX -4.13%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.11%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.95%

LPTX -1.65%

LQDA -0.81%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.06%

LYEL -33.43%

LYRA 0.93%

MACK 0.10%

MBIO -11.00%

MBRX -2.57%

MCRB 2.88%

MDGL -3.53%

MDNA -13.16%

MDWD 0.03%

MDXG -2.58%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX 0.54%

MIRM -1.89%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.57%

MLYS -6.41%

MNKD -0.95%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.20%

MORF -2.77%

MREO -4.29%

MRKR 2.68%

MRNA -5.05%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.21%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.72%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.89%

NLSP 5.88%

NLSPW 26.67%

NMRA -3.65%

NMTR -42.97%

NOVN -24.84%

NRBO 12.63%

NRIX -0.34%

NRSN -5.18%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.55%

NTRBW -31.07%

NUVL -1.53%

NVAX -2.36%

NVCT 2.38%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA 0.00%

OCGN 3.39%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.44%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.49%

ORMP 21.43%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.29%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.48%

PDSB -3.63%

PEPG 2.56%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.36%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.19%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -10.64%

PRAX 0.92%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.60%

PRTA -2.34%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.18%

PSTX -0.78%

PTCT -0.64%

PTE -0.82%

PTGX -1.39%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.33%

RCKT -7.90%

REGN -0.26%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -2.78%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.29%

RLAY -3.56%

RLMD 0.33%

RLYB -0.34%

RNA 0.18%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.99%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.22%

RPTX -2.35%

RUBY 2.70%

RVLP -32.05%

RVMD -0.98%

RVMDW -30.00%

RVNC 2.34%

RVPH -0.81%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.74%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.83%

SANA -3.78%

SAVA -0.36%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.40%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -6.38%

SLGL 2.97%

SLN -4.76%

SLNO -4.14%

SLRX 6.07%

SLS -2.14%

SMMT -2.62%

SNDX 1.43%

SNGX -3.40%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.20%

SRRA 0.00%

SRRK -2.17%

SRZN -2.45%

STAB 0.00%

STOK -5.18%

STRO -2.84%

STSA 0.00%

STTK -2.39%

SURF -0.93%

SVRA -4.87%

SWTX 0.16%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 2.74%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.07%

TENX -1.27%

TERN -7.57%

TFFP -5.33%

TGTX -3.18%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -3.10%

TNGX -2.60%

TNXP -6.11%

TNYA -5.43%

TPST 2.67%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.34%

TSVT -2.93%

TTNP -7.79%

TVTX 0.88%

TYRA -7.43%

UBX -0.71%

UNCY -3.90%

URGN -1.52%

UTHR -0.38%

VACC 11.36%

VALN -2.89%

VAXX 83.69%

VBIV 0.78%

VBLT -8.77%

VCEL -0.16%

VCNX 10.35%

VCYT -1.03%

VERA -3.78%

VERU -0.57%

VERV -2.87%

VIGL 7.53%

VINC 2.96%

VIR 0.76%

VIRI -1.61%

VIRX 2.40%

VKTX -1.36%

VLON -13.04%

VNDA -2.61%

VOR -2.02%

VRCA 0.00%

VRDN -4.24%

VRNA -1.60%

VRPX 0.38%

VRTX 0.39%

VSTM -2.10%

VTGN -1.05%

VTVT -2.97%

VTYX -1.04%

VXRT -3.84%

VYGR -0.77%

VYNE -4.34%

VYNT 7.78%

WINT -3.24%

WVE -4.19%

XBIO 0.93%

XBIT -2.71%

XCUR 3.58%

XENE -2.81%

XERS 2.14%

XFOR 2.86%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.83%

ZNTL -0.83%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-07-08	Innoviva Strategic Opportunities Llc	Buy	7 598 814	Common Stock
2022-07-07	Tommasi Ruben	Sell	39 596	Common Stock
2022-07-11	Tommasi Ruben	Sell	150 000	Common Stock
2022-07-11	Tommasi Ruben	Sell	98 700	Stock Option (right to buy)
2022-07-11	Tommasi Ruben	Sell	50 000	Stock Option (right to buy)

INSIDER POWER
52.71
Last 98 transactions
Buy: 9 607 238 \| Sell: 3 128 729

Volume Correlation

Long: 0.20 (neutral)

Short: -0.50 (neutral)

Signal:(62.724) Neutral

Entasis Therapeutics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entasis Therapeutics Correlation - Currency/Commodity

0.33
( neutral )

-0.29
( neutral )

0.00
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.69
( moderate negative )

Entasis Therapeutics Financials

Annual	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.10

FY	2019
Revenue:	$7.00M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-3.33

Financial Reports:

No articles found.

Entasis Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Entasis Therapeutics

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts. Entasis Therapeutics Holdings Inc. operates as a subsidiary of Innoviva, Inc.